Blood Test May Predict Whether Patients With Glaucoma Will Continue To Lose Vision Following Treatment, Research Suggests

HealthDay (7/16, Thompson) says “an experimental blood test might be able to predict whether” patients with glaucoma “will continue to lose their vision following treatment, researchers report.” Researchers found that “a biochemical called nicotinamide adenine dinucleotide (NAD) tends to be lower in people with glaucoma compared to those without the eye disease.” Additionally, patients with glaucoma who have “lower NAD levels than others tended to lose their vision more quickly, even after receiving treatment to lower fluid pressure in the eye.” The findings were published in Nature Medicine.